Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:GNMX

Aevi Genomic Medicine (GNMX) Stock Price, News & Analysis

Aevi Genomic Medicine logo

About Aevi Genomic Medicine Stock (NASDAQ:GNMX)

Advanced Chart

Key Stats

Today's Range
$0.15
$0.18
50-Day Range
$0.17
$0.19
52-Week Range
$0.11
$0.35
Volume
2.95 million shs
Average Volume
3.16 million shs
Market Capitalization
$12.89 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive GNMX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Aevi Genomic Medicine and its competitors with MarketBeat's FREE daily newsletter.

GNMX Stock News Headlines

Plc Astrazeneca's Net Worth
Aevi Genomic Medicine, Inc.
Market Panic: Trump Just Dropped a Bomb on Your Stocks
tock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tariffs just lit the fuse. Millions of investors are blindsided as stocks plunge… but this is only Phase 1. If you're still holding the wrong assets, you could lose 30% or more in the coming weeks.
See More Headlines

GNMX Stock Analysis - Frequently Asked Questions

Aevi Genomic Medicine, LLC (NASDAQ:GNMX) posted its quarterly earnings data on Thursday, November, 1st. The biotechnology company reported ($0.12) earnings per share for the quarter, topping the consensus estimate of ($0.15) by $0.03.

Based on aggregate information from My MarketBeat watchlists, some other companies that Aevi Genomic Medicine investors own include Inovio Pharmaceuticals (INO), Novavax (NVAX), SCYNEXIS (SCYX), Protalix BioTherapeutics (PLX), iBio (IBIO), Immunomedics (IMMU) and Catalyst Pharmaceuticals (CPRX).

Company Calendar

Last Earnings
11/01/2018
Today
7/12/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Biological Products, Except Diagnostic
Sub-Industry
N/A
Current Symbol
NASDAQ:GNMX
Previous Symbol
NASDAQ:MDGN
CIK
1138776
Fax
N/A
Employees
14
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($0.50)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$30.77 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-898.31%
Return on Assets
-286.73%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.65
Quick Ratio
0.65

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.12 per share
Price / Book
1.38

Miscellaneous

Outstanding Shares
77,714,000
Free Float
N/A
Market Cap
$12.89 million
Optionable
Optionable
Beta
1.13
Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report

This page (NASDAQ:GNMX) was last updated on 7/13/2025 by MarketBeat.com Staff
From Our Partners